IONS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: IONS Shares Outstanding History and IONS YTD Return |
IONS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: IONS Shares Outstanding History and IONS YTD Return |
IONS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+15.36% CAGR Mouse over chart for data details
|
IONS Stock Price Chart |
About Ionis Pharmaceuticals Inc |
Ionis Pharmaceuticals is engaged in RNA-targeted therapeuty. Co.'s commercial products are SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA injection for intrathecal use is a survival motor neuron-2 directed antisense medicine indicated for the treatment of spinal muscular atrophy in pediatric and adult patients. TEGSEDI injection is an RNA-targeted medicine indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. We show 58 historical shares outstanding datapoints in our IONS shares outstanding history coverage, used to compute IONS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IONS market cap history over the course of time is important for investors interested in comparing IONS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IONS versus a peer is one thing; comparing IONS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IONS can fluctuate over the course of history. With this page we aim to empower investors researching IONS by allowing them to research the IONS market cap history. |
IONS Current Stock Quote |
Free IONS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
IONS Share Performance |
Market Cap Peers |
Ionis Pharmaceuticals (IONS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IOVA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.